Summary
Mauricio Tavares is a medicinal chemist and Senior Scientist with over a decade of hands-on drug discovery experience, currently leading oncology-focused medicinal chemistry programs at Dana-Farber Cancer Institute and Harvard Medical School. He has steered multiple programs from hit identification to lead optimization and a Phase I candidate, blending deep synthetic expertise with structure-, ligand-, and fragment-based design and an eye for pragmatic go/no-go decisions. Mauricio designs diverse modalities—small molecules, PROTACs, macrocyclic chelators for radioligand therapy, and covalent modulators—and creates bespoke chemical probes (PAL, biotinylated, fluorescent) to accelerate target validation. He routinely integrates ADME-Tox, pharmacology, DMPK, and computational tools (docking, MD, QSAR) into SAR-driven campaigns, and has a proven record managing CROs, mentoring scientists, and contributing to IND-enabling studies and patents. Trained with a PhD from USP and enriched by international research stints, he combines academic rigor with translational impact and a knack for designing efficient synthetic routes that move projects faster than expected.
11 years of coding experience
8 years of employment as a software developer
Doctor of Philosophy - PhD, Medicinal Chemistry, Doctor of Philosophy - PhD, Medicinal Chemistry at USP - Universidade de São Paulo
Mackenzie Presbyterian University